Month: January 2022

Categories
Pharmaceutical

PCR Master Mix Market To Witness A Pronounce Growth During 2021 To 2031

Mass technological transformation of the global healthcare industry has left key market participants struggling to traverse the complexities of medical and life sciences. Given the shifting dynamics of the global healthcare sector, pharma and biotech companies are taking measured efforts to improve patient outcomes in an effective manner, while keeping a careful watch on the bottom line.

Much is being said about Artificial Intelligence taking over manual back office and supply chain operations in the healthcare ecosystem, threatening to replace physicians from critical claims processing roles. This might put pressure on pharmaceutical companies to ensure readiness to the new technology.

Big data and analytics will drive patient outcomes in a big way, and the coming years will witness a growing emphasis on healthcare service providers in the business of gathering and processing patient health data.

Creating outcome-oriented financial models to maximize reimbursements in value-based healthcare will be a strategic shift from the traditional fees-for-services model. This implies that pharmaceutical companies will need to devise appropriate measures to optimize costs and improve the quality of patient care.

The study on the Global PCR Master Mix Market published by Fact.MR is a comprehensive analysis of the key factors that are likely to determine the growth of PCR Master Mix Market in the upcoming years.

PCR Master Mix Market: Overview

Based on the product type, the PCR master mix market has been segmented into high-fidelity PCR master mix, Real Time qPCR master mix and others. High fidelity PCR master mix is expected to hold a large revenue share in the PCR master mix market.

Based on the application, the global PCR master mix market has been segmented into PCR amplification of DNA fragments, high throughput PCR, DNA labeling and others.

PCR amplification of DNA fragments is expected to be the most common application Based on the end user, the global PCR master mix market has been segmented into research centers, biotechnology institutes and others. Research centers are expected to hold a large revenue share in the PCR master mix market.

Request Sample   https://www.factmr.com/connectus/sample?flag=S&rep_id=4709                                             

PCR Master Mix Market Segmentation

By Region

  • North America
  • Europe
  • East Asia
  • South Asia
  • Latin America
  • Oceania
  • Middle East & Africa

By Drugs

  • High-Fidelity PCR Master Mix
  • Real Time qPCR Master Mix
  • Others

 Request Customization https://www.factmr.com/connectus/sample?flag=RC&rep_id=4709                                              

Essential Takeaways from the PCR Master Mix Market Report

  • Comparison of prominent players operating in the PCR Master Mix Market.
  • Recent developments and key strategies adopted by market players.
  • Study of the micro and macro-economic growth indicators.
  • Impact of the various factors on the value chain of the PCR Master Mix Market.
  • Growth opportunities for emerging market players in various regional markets.
  • Current trends influencing the scenario of the PCR Master Mix Market.

Important queries related to the PCR Master Mix Market addressed in the report:

  1. Who are the most prominent players in the PCR Master Mix Market?
  2. What are the factors that are likely to hinder the growth of the PCR Master Mix Marketduring the forecast period (2021-2031)?
  3. Why is the concentration of tier-1 companies high in specific region?
  4. How are the soaring prices of raw materials impacting the demand for keyword?
  5. Why are market players eyeing opportunities in particular region?

 Request ToC   https://www.factmr.com/connectus/sample?flag=T&rep_id=4709                                                 

Strategic Points Covered in Table of Content of Global PCR Master Mix Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the PCR Master Mix Market
Chapter 2: Exclusive Summary – the basic information of the PCR Master Mix Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the Ascorbyl Palmitate
Chapter 4: Presenting the PCR Master Mix Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country 2016-2020
Chapter 6: Evaluating the leading manufacturers of the PCR Master Mix Market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions (2021-2031)
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source
finally, PCR Master Mix Market is a valuable source of guidance for individuals and companies.

For More Insights- https://www.einpresswire.com/article/556866054/sun-control-window-films-market-automotive-applications-to-garner-one-third-market-share

About Fact.MR   

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Categories
Pharmaceutical

Eosinophilic Granulomatosis Market Estimated To Flourish At By 2031

Mass technological transformation of the global healthcare industry has left key market participants struggling to traverse the complexities of medical and life sciences. Given the shifting dynamics of the global healthcare sector, pharma and biotech companies are taking measured efforts to improve patient outcomes in an effective manner, while keeping a careful watch on the bottom line.

Much is being said about Artificial Intelligence taking over manual back office and supply chain operations in the healthcare ecosystem, threatening to replace physicians from critical claims processing roles. This might put pressure on pharmaceutical companies to ensure readiness to the new technology.

Big data and analytics will drive patient outcomes in a big way, and the coming years will witness a growing emphasis on healthcare service providers in the business of gathering and processing patient health data.

Creating outcome-oriented financial models to maximize reimbursements in value-based healthcare will be a strategic shift from the traditional fees-for-services model. This implies that pharmaceutical companies will need to devise appropriate measures to optimize costs and improve the quality of patient care.

The study on the Global Eosinophilic Granulomatosis Market published by Fact.MR is a comprehensive analysis of the key factors that are likely to determine the growth of Eosinophilic Granulomatosis Market in the upcoming years. Further, the study dives deep to investigate the micro and macro-economic parameters that are expected to influence the global scenario of the Eosinophilic Granulomatosis Market during the forecast period (2021-2031).

The report examines the current trends, growth opportunities, restraints, and market drivers that are projected to influence the overall dynamics of the Eosinophilic Granulomatosis Market in the assessment period.

Request Sample   https://www.factmr.com/connectus/sample?flag=S&rep_id=4697                                             

Eosinophilic Granulomatosis Market Segmentation

By Region

  • North America
  • Europe
  • East Asia
  • South Asia
  • Latin America
  • Oceania
  • Middle East & Africa

By Drugs

  • Corticosteroids
  • Immunosuppressive Agents
  • Biologics
  • Immune Globulins

 Request Customization https://www.factmr.com/connectus/sample?flag=RC&rep_id=4697   

Eosinophilic Granulomatosis Market: Key Players

The global market for eosinophilic granulomatosis is consolidated withlarge number of market players. Examples of some of the primary key players operating in the global eosinophilic granulomatosis market are Genentech Inc. (F. Hoffmann-La Roche AG), Cephalon Inc. (Teva Pharmaceutical Industries Ltd.), Amgen Inc., Sanofi S.A., Koninklijke DSM N.V, AstraZeneca plc, Novartis International AG,GlaxoSmithKline LLC, Pharmaceuticals Holdings Corp, Baxter Healthcare Corporation, andamong others.

 Essential Takeaways from the Eosinophilic Granulomatosis Market Report

  • Comparison of prominent players operating in the Eosinophilic Granulomatosis Market.
  • Recent developments and key strategies adopted by market players.
  • Study of the micro and macro-economic growth indicators.
  • Impact of the various factors on the value chain of the Eosinophilic Granulomatosis Market.
  • Growth opportunities for emerging market players in various regional markets.
  • Current trends influencing the scenario of the Eosinophilic Granulomatosis Market.

Important queries related to the Eosinophilic Granulomatosis Market addressed in the report:

  1. Who are the most prominent players in the Eosinophilic Granulomatosis Market?
  2. What are the factors that are likely to hinder the growth of the Eosinophilic Granulomatosis Marketduring the forecast period (2021-2031)?
  3. Why is the concentration of tier-1 companies high in specific region?
  4. How are the soaring prices of raw materials impacting the demand for keyword?
  5. Why are market players eyeing opportunities in particular region?

 Request ToC   https://www.factmr.com/connectus/sample?flag=T&rep_id=4697                                                

Strategic Points Covered in Table of Content of Global Eosinophilic Granulomatosis Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Eosinophilic Granulomatosis Market
Chapter 2: Exclusive Summary – the basic information of the Eosinophilic Granulomatosis Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the Ascorbyl Palmitate
Chapter 4: Presenting the Eosinophilic Granulomatosis Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country 2016-2020
Chapter 6: Evaluating the leading manufacturers of the Eosinophilic Granulomatosis Market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions (2021-2031)
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source
finally, Eosinophilic Granulomatosis Market is a valuable source of guidance for individuals and companies.

For More Insights- https://www.einpresswire.com/article/556693095/advancements-in-the-technology-of-avionics-propels-the-business-aircraft-manufacturing-industry

About Fact.MR   

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Categories
Pharmaceutical

Acute Hepatic Porphyria (APH) Market Expansion To Be Persistent During 2021-2031

Mass technological transformation of the global healthcare industry has left key market participants struggling to traverse the complexities of medical and life sciences. Given the shifting dynamics of the global healthcare sector, pharma and biotech companies are taking measured efforts to improve patient outcomes in an effective manner, while keeping a careful watch on the bottom line.

Much is being said about Artificial Intelligence taking over manual back office and supply chain operations in the healthcare ecosystem, threatening to replace physicians from critical claims processing roles. This might put pressure on pharmaceutical companies to ensure readiness to the new technology.

Request Sample   https://www.factmr.com/connectus/sample?flag=S&rep_id=4696

Big data and analytics will drive patient outcomes in a big way, and the coming years will witness a growing emphasis on healthcare service providers in the business of gathering and processing patient health data.

Creating outcome-oriented financial models to maximize reimbursements in value-based healthcare will be a strategic shift from the traditional fees-for-services model. This implies that pharmaceutical companies will need to devise appropriate measures to optimize costs and improve the quality of patient care.

Acute Hepatic Porphyria (APH)Market: Overview

The acute hepatic porphyria (APH) market is expected to experience moderate growth over the forecast period owing to higher government initiative to develop innovative therapeutics for acute hepatic porphyria (APH).Byindication, acute intermittent porphyria (AIP)segment is expected to hold the major market share in the acute hepatic porphyria (APH) market. Among drug class, intravenous heminsegment is expected to hold the major market share in the acute hepatic porphyria (APH) market.

Recently, in the end of 2019, FDA has approvedGIVLAARI® (givosiran injections)first and only one treatment for acute hepatic porphyria (APH)manufactured by the Alnylam Pharmaceuticals, Inc. Among distribution channels, retail pharmacies segment is expected to be the leading revenue generating segment in acute hepatic porphyria (APH) market owing to higher patient footfall.

Request Customization https://www.factmr.com/connectus/sample?flag=RC&rep_id=4696

Acute Hepatic Porphyria (APH)Market: Segmentation

The acute hepatic porphyria (APH)market can besegmented into indication, drug type, distribution channels and geography.

Based on indication, the global acute hepatic porphyria (APH)market is segmented as:

  • Acute intermittent Porphyria (AIP)
  • Variagate Porphyria (VP)
  • Hereditary Coproporphyria (HC)
  • Hereditary Deficit of Delta-aminolevulinic Acid Dehydratase (HDAD)

Based on drug type, the global acute hepatic porphyria (APH)market is segmented as:

  • Intravenous Hemin
  • Carbohydrate Nutrition and Hydration
  • Hypertonic Saline
  • Anti-epileptics (Short-acting)

Based on the distribution channels, the global acute hepatic porphyria (APH)market is segmented as:

  • Hospital Pharmacies
  • Drug Stores
  • Retail Pharmacies
  • Online Pharmacies

Request ToC   https://www.factmr.com/connectus/sample?flag=T&rep_id=4696

Acute Hepatic porphyria (APH)Market: Key Players

The global market for acute hepatic porphyria (APH)is consolidated withlarge number of market players. Examples of some of the primary key players operating in the global acute hepatic porphyria (APH)market are Recordati Rare Diseases Inc., Lundbeck Inc., andAlnylam Pharmaceuticals, Inc.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

For More Insights- https://www.einpresswire.com/article/557143957/demand-for-reinforced-hydraulic-hose-is-surged-owing-to-its-application-in-industrial-hydraulic-system-at-high-pressure

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Image Guided Radiotherapy Market Estimated To Record Highest CAGR By 2031

Mass technological transformation of the global healthcare industry has left key market participants struggling to traverse the complexities of medical and life sciences. Given the shifting dynamics of the global healthcare sector, pharma and biotech companies are taking measured efforts to improve patient outcomes in an effective manner, while keeping a careful watch on the bottom line.

Much is being said about Artificial Intelligence taking over manual back office and supply chain operations in the healthcare ecosystem, threatening to replace physicians from critical claims processing roles. This might put pressure on pharmaceutical companies to ensure readiness to the new technology.

Big data and analytics will drive patient outcomes in a big way, and the coming years will witness a growing emphasis on healthcare service providers in the business of gathering and processing patient health data.

Request Sample   https://www.factmr.com/connectus/sample?flag=S&rep_id=4001

Creating outcome-oriented financial models to maximize reimbursements in value-based healthcare will be a strategic shift from the traditional fees-for-services model. This implies that pharmaceutical companies will need to devise appropriate measures to optimize costs and improve the quality of patient care.

Market Overview

Image Guided Radiotherapy (IGRT) is any imaging at the pre-treatment and treatment that prompts an activity that can improve or check the precision of radiotherapy. IGRT encompasses a wide scope of techniques extending from simple visual field arrangement checks, through to the more complex volumetric imaging that permits direct visualization of the radiotherapy target volume.

Image Guided Radiotherapy includes the utilization of various scans and X-rays to treat an area of malignant growth. Image Guided Radiotherapy (IGRT) shape the radiotherapy shafts around the area of the malignant tissue. It utilizes X-rays and scans similar CT scans previously and during the radiotherapy treatment. It improves the accuracy and precision of treatment delivery.

Request Customization https://www.factmr.com/connectus/sample?flag=RC&rep_id=4001

Image Guided Radiotherapy market: Segmentation

Image Guided Radiotherapy market has been segmented on basis of device type, technology, Application and end user.

  • Segmentation of Image Guided Radiotherapy market on basis of devices:
    • X-ray computed tomography
      • digital X-ray
      • computed tomography (CT)
      • conventional CT
      • optical tracking
      • cone beam
      • MVCT
      • Others
    • magnetic resonance imaging (MRI)
    • positron emission tomography
    • Others
  • Segmentation of Image Guided Radiotherapy market on basis of technology:
    • radiation-based System
      • electronic portal imaging devices (EPID)
      • cone beam CT
      • Fan beam
      • Others
    • non-radiation based systems
      • ultrasound-based systems,
      • camera-based or optical tracking systems
      • MRI-guided IGRT
      • Others
  • Segmentation of Image Guided Radiotherapy market on basis of Application:
    • Radiographic imaging
    • Fluoroscopic imaging
    • Tomographic imaging
    • Functional/molecular imaging
  • Segmentation of Image Guided Radiotherapy market on basis of end user:
    • Hospitals
    • Research institute
    • Cancer centers
    • Others

 Request ToC   https://www.factmr.com/connectus/sample?flag=T&rep_id=4001

Image Guided Radiotherapy market: Key players

Major players in Image Guided Radiotherapy market are

  • ViewRay
  • General Electric Company
  • Hitachi, Ltd.
  • Siemens AG
  • Koninklijke Philips N.V.
  • TOSHIBA CORPORATION
  • Varian Medical Systems, Inc
  • Vision RT Ltd.
  • Scranton Gillette Communications
  • XinRay Systems, C-RAD

For More Insights- https://www.einpresswire.com/article/557143001/worldwide-revenue-share-of-undercarriage-components-for-mini-excavators-is-expected-to-account-nearly-us-6-5-billion

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Glucagon Therapy Market Expansion Projected To Gain An Uptick During 2021-2031

Mass technological transformation of the global healthcare industry has left key market participants struggling to traverse the complexities of medical and life sciences. Given the shifting dynamics of the global healthcare sector, pharma and biotech companies are taking measured efforts to improve patient outcomes in an effective manner, while keeping a careful watch on the bottom line.

Much is being said about Artificial Intelligence taking over manual back office and supply chain operations in the healthcare ecosystem, threatening to replace physicians from critical claims processing roles. This might put pressure on pharmaceutical companies to ensure readiness to the new technology.

Request Sample   https://www.factmr.com/connectus/sample?flag=S&rep_id=4004

Big data and analytics will drive patient outcomes in a big way, and the coming years will witness a growing emphasis on healthcare service providers in the business of gathering and processing patient health data.

Creating outcome-oriented financial models to maximize reimbursements in value-based healthcare will be a strategic shift from the traditional fees-for-services model. This implies that pharmaceutical companies will need to devise appropriate measures to optimize costs and improve the quality of patient care.

Market Overview

Glucagon therapy is primarily used in the management of hypoglycemia in adults, children, and pregnant women. Glucagon secreted by pancreas which is released in form of glucose that raise blood glucose levels by liver to convert glycogen to glucose. Glucagon is a medication for the treatment of severe low blood sugar level (Hypoglycemia). Glucagon therapy comprises of injectable and nasal form for the treatment of hypoglycemia.

Request Customization https://www.factmr.com/connectus/sample?flag=RC&rep_id=4004

Glucagon Therapy Market: Drivers & Restraints

Glucagon therapy market is growing attributable to use as a cardiovascular stimulant after beta-blocker or calcium channel blocker overdose also glucagon therapy is utilized to restrain gastrointestinal motility to aid radiologic examinations. It may also be used to help make a detection of insulin. Increase in the number of mortality cases due to hypoglycemia, increase in the predominance of hypoglycemia in diabetic patients are the factors which contribute in the growth of glucagon therapy market.

Increment in prevalence rate of hypoglycemia due to other diseases such as severe falciparum malaria have are other factors which can be responsible for the growth of glucagon therapy market. Glucagon therapy market is growing because of increment being used of beta blocker lethality as glucagon is generally accepted as an antidote, especially as first-line treatment in β-blocker overdose as Cardiovascular medication overdose was the fourth driving reason of death.

Request ToC   https://www.factmr.com/connectus/sample?flag=T&rep_id=4004

Glucagon Therapy Market: Segmentation

Glucagon therapy market has been segmented on basis of product type, application, end user and regions.

Glucagon Therapy Market can Segmentation on basis of product type

  • Inject Glucagon
  • Nasal Glucagon

Glucagon Therapy Market can Segmentation on basis of application type

  • General Use
  • Emergency kit
  • Diagnostic and Motility
  • Cardiogenic Shock
  • Others

Glucagon Therapy Market can Segmentation on basis of end user

  • Hospitals
  • Speciality Clinics

Glucagon Therapy Market: Key Players

The key players operating in the Glucagon therapy market are

  • Eli Lilly
  • Taj Pharmaceuticals
  • Torrent Labs
  • Xeris Pharmaceuticals
  • Novo Nordisk
  • Fresenius Kabi.

For More Insights- https://www.einpresswire.com/article/556506843/growing-of-polyurethane-structural-insulated-panels-is-projected-to-take-demand-growth-at-5-cagr-over-the-next-10-years

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Hemoglobin Testing Systems Market To Witness Increase In Revenues By 2031

Mass technological transformation of the global healthcare industry has left key market participants struggling to traverse the complexities of medical and life sciences. Given the shifting dynamics of the global healthcare sector, pharma and biotech companies are taking measured efforts to improve patient outcomes in an effective manner, while keeping a careful watch on the bottom line.

Much is being said about Artificial Intelligence taking over manual back office and supply chain operations in the healthcare ecosystem, threatening to replace physicians from critical claims processing roles. This might put pressure on pharmaceutical companies to ensure readiness to the new technology.

Big data and analytics will drive patient outcomes in a big way, and the coming years will witness a growing emphasis on healthcare service providers in the business of gathering and processing patient health data.

Request Sample   https://www.factmr.com/connectus/sample?flag=S&rep_id=3985

Creating outcome-oriented financial models to maximize reimbursements in value-based healthcare will be a strategic shift from the traditional fees-for-services model. This implies that pharmaceutical companies will need to devise appropriate measures to optimize costs and improve the quality of patient care.

Market Overview

Hemoglobin is a critical indicator of general health. Its measurement is important diagnostic tool for the diseases like anemia, jaundice etc. The hemoglobin test system is an instrument which is used to calculate the hemoglobin content in the blood by spectrophotometric measurement technique. However, at present the photometric methods used in the hemoglobin testing systems are user-friendly, and mitigating the pain to blood donor and minimizing the risk of infection.

Point-of-care (POC) test in hematology gained continuous growth in very short period of time. The rapid technological advancement and global uptake have led to the growth and development of several hemoglobin testing devices. Now a day hemoglobin testing systems are noninvasive and fast as compare to the traditional method, which can produce results within 30 seconds.

Request Customization https://www.factmr.com/connectus/sample?flag=RC&rep_id=3985

Hemoglobin Testing Systems Market: Drivers and Restraints

Increasing the prevalence of blood disorders, and the presence of advanced and sophisticated technologies are anticipated to propel the growth of hemoglobin testing systems market. The demand for hemoglobin testing systems is expected to grow over the forecast period, due to the ability to deliver the quick and fast results, which helps to physicians to deliver the proper treatment on the diseases.

Moreover, increasing the awareness about the blood testing program and blood donation camps expected to fuel the growth of hemoglobin testing systems market in coming days. Sampling error during the blood testing by the user and shorter life span along with the decreasing sensitivity of the test system, increased the cost of the kit reagents may restrain the hemoglobin testing systems market.

Regional government initiative in developing countries like India, Venezuela, and Vietnam to control the anemia, such kind of factor may drive the growth of hemoglobin testing systems market in the future.

 Request ToC   https://www.factmr.com/connectus/sample?flag=T&rep_id=3985

Hemoglobin Testing Systems Market: Segmentation

Tentatively, the global hemoglobin testing systems market can be segmented on the basis of product Type, operating type, end user and geography.

Based on product type, the hemoglobin testing systems market is segmented as:

  • Bench-top
  • Handheld
  • Others

Based on operating type, the hemoglobin testing systems market is segmented as:

  • Automatic
  • Semi-Automatic

Based on end users, the hemoglobin testing systems market is segmented as:

  • Hospitals
  • Diagnostic laboratories
  • Home

Hemoglobin Testing Systems Market: Key Players

Some of the key players operating in the global hemoglobin testing systems market are

  • Mindray Medical International Limited
  • Sysmex Corporation
  • Mindray Medical International Limited
  • Beckman Coulter, Inc.
  • Abbott Laboratories
  • Roche Diagnostics
  • Bio-Rad Laboratories, Inc.
  • Nihon Kohden Corporation
  • Siemens Healthineers
  • HemoCue India

For More Insights- https://www.einpresswire.com/article/556502949/growing-demand-for-sanitizers-during-pandemic-gives-traction-to-the-market-for-99-triethanolamine

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com

 

Categories
Pharmaceutical

An Above Average CAGR Estimated To Be Maintained By Histology Embedding System Market During 2021-2031

Market Overview

Embedding is the process which involves the enclosure of a particular tissue or specimen in an embedding medium by making use of a mould. The tissue samples are very fragile and thin and require solid support for being embedded. Histology embedding systems are the devices which carry out this procedure. The burden of increasing diseases around the globe such as cancer, diabetes, heart conditions are to be tackled efficiently and requires the involvement of significant and evident research and analysis of tissues and other specimens.

Request Sample   https://www.factmr.com/connectus/sample?flag=S&rep_id=3983

These factors are impactful in spreading the market of Histology embedding systems. Histology embedding systems are an essential part of processing tissues and other biological samples. The Histology embedding systems are involved in carrying out the initial processes of a wide variety of testing and analysis. The wide range of applications of Histology embedding systems in various fields of science is creating its demand day by day.

Histology Embedding System Market: Drivers and Restraints

Histology and Histopathology is a growing field in science and requires a wide range of equipment to function. Histology embedding systems is one priority product to initiate various processes. The burden of unidentified diseases and diseases without a cure is increasing on a fast pace. This scenario has given rise to innovative technologies, awareness and increased R&D in a lot of countries.

The need of Histology Embedding systems is also in diagnostic purposes and molecular profiling this gives an added advantage to the Histology Embedding Systems Market and boosts the Histology embedding systems Market in places such as hospitals and specialty clinics. Embedding is an evident step in ensuring quality histology. Histology embedding systems are also used in plant tissue culture labs the market of Histology Embedding System also has a scope in this area of science.

Request Customization https://www.factmr.com/connectus/sample?flag=RC&rep_id=3983

Histological Embedding Systems Market: Segmentation

The global Histology Embedding System market can be segmented on the basis of Paraffin Chamber Capacity, Applications, Modularity and End Users.

Based on Paraffin Chamber Capacity, the global Histology Embedding System market is segmented as:

  • 2 liters – 3 liters
  • 4liters – 5liters
  • 6 liters
  • 7 liters
  • 5 liters

Based on Applications, the global Histology Embedding System market is segmented as:

  • Histology
  • Histopathology
  • Plant Tissue Culture
  • Molecular Profiling
  • Diagnostics
  • Cancer Research
  • Immunohistochemistry

Based on Modularity, the global Histology Embedding System market is segmented as:

  • Single module system
  • 2 module system
  • 3 module system

Based on End users, the global Histology Embedding System market is segmented as:

  • Hospitals
  • Specialty Clinics
  • Cancer Research Labs
  • Pathological Labs
  • Histopathological labs
  • Plant Tissue Culture labs

Request ToC   https://www.factmr.com/connectus/sample?flag=T&rep_id=3983

Histology Embedding System Market: Key Players

Some of the key players in the global Histology Embedding System Market are

  • IHC WORLD LLC.
  • Danaher
  • Electron Microscopy Sciences
  • KALSTEIN
  • SM Scientific Instruments Pvt. Ltd.
  • MEDITE GmbH
  • Thermo Fisher
  • Ted Pella Inc.
  • Sakura
  • VirtualExpo Group
  • WWR International LLC.,
  • Rushabh Instruments LLC.

For More Insights- https://www.einpresswire.com/article/556506843/growing-of-polyurethane-structural-insulated-panels-is-projected-to-take-demand-growth-at-5-cagr-over-the-next-10-years

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Tumour-Induced Osteomalacia Market Growth, Opportunities, Ongoing Trends, and Forecast to 2031 | Fact.MR

Tumour-Induced Osteomalacia Market research Report is an inestimable supply of insightful data for business strategists. This Tumour-Induced Osteomalacia Market study provides extensive data which enlarge the understanding, scope, and application of this report.

A specified study of the competitive landscape of the global Tumour-Induced Osteomalacia Market has allow, providing insights into the corporate profiles, financial position, recent developments, mergers and acquisitions, and therefore the SWOT analysis. This analysis report will provide a patent subject to reader’s concern regarding the overall market situation to further choose on this market project.

Get Exclusive Free Sample Report: https://www.factmr.com/connectus/sample?flag=B&rep_id=5255

The report discusses in detail the various important aspects of the Tumour-Induced Osteomalacia market. The report has an intelligent insight on critical aspects that are essential to good growth in the Tumour-Induced Osteomalacia market. Some of these features include market size, growth, revenue, sales, demand, risks, threats, opportunities, economic forecast and history, and much more. The report is based on factual data assessed by our research analysts to give our clients a complete overview of the Tumour-Induced Osteomalacia market landscape and prepare a business canvas accordingly.

The Tumour-Induced Osteomalacia Market report profiles the successive companies, which includes: – Kyowa Kirin Co., Ltd., Taizhou Hisound Pharmaceutical Co., Ltd., Zhejiang Garden Biochemical High-tech Co., Ltd., Kingdomway Nutrition, Inc., Amgen Inc., Forgo Pharmaceuticals Pvt. Ltd., Abbott, Solvay, GE Healthcare, Siemens.

Fact.MR analysts are currently analyzing and coordinating their insights on the effect of COVID-19 across diverse industry verticals. These insights are quite promising for several businesses and ventures to cope up with this unprecedented downturn and take effective strategic decisions to expand and proliferate within a competitive business ecosystem.

Enquiry Before Buying: https://www.factmr.com/connectus/sample?flag=EB&rep_id=5255

By treatment, the global tumour-induced osteomalacia market is further segmented into:

  • Drugs
    • Burosumab-twza
    • Cinarcalcet
  • Supplements
    • Calcium (Cinarcalcet,
    • Vitamin D (Calcitriol or Alphacalcidio)
    • Phosphorus
  • Surgery

By diagnosis, the global tumour-induced osteomalacia market is further segmented into:

  • Laboratories
    • Elevated blood Fibroblast growth factor 23 (FGF-23)
    • Serum calcium, PTH, vitamin D
    • Hyperphosphaturia (Secondary effects of the FDF-23)
    • Hypophosphatemia (Secondary effects of the FDF-23)
  • Bone Scan
    • Magnetic Resonance Imaging (MRI)
    • Computed Tomography (CT Scan)
  • Differential Diagnosis
    • Vitamin D metabolism and deficiency
    • Osteoporosis
    • Renal Osteodystrophy
    • Others

By end-user, the global tumour-induced osteomalacia market is further segmented into:

  • Hospitals
  • Clinics

Market Segment by Regions, regional analysis covers:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Middle East Africa

Pre Book This Report: https://www.factmr.com/checkout/5255

Reasons why you should buy this report:

Understand the Current and future of the Tumour-Induced Osteomalacia Market in both Established and emerging markets.
The report assists in relocating the business strategies by accentuate the Tumour-Induced Osteomalacia business priorities.
The report throws light on the segment anticipated to dominate the Tumour-Induced Osteomalacia industry and market.
Forecasts the regions expected to perceive ascension.
The newest developments within the Tumour-Induced Osteomalacia industry and details of the industry leaders alongside their market share and methods.
Saves time on the entry-level research as the report contains significant data concentrating growth, size, key players, and segments of the industry.
Save time carrying out entry-level research by characterizing the growth, size, major players and segments within the Global Market.

Explore Fact.MR’s Trending Report – https://www.globenewswire.com/en/news-release/2019/09/11/1914156/0/en/Ill-Effects-of-Self-medication-Practices-to-Ramp-up-the-Adoption-of-Earwax-Removal-Aids-Fact-MR.html

Why choose Fact.MR?

Reports published by Fact.MR are a result of the combination of our experts and digital technologies. We thrive to provide innovative business solutions to the clients as well as tailor the reports aligning with the clients’ requisites. Our analysts perform comprehensive research to offer ins and outs of the current market situation. Clients across various time zones tend to utilize our 24/7 service availability.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Pharmaceutical

Nonmetastatic Castrationresistant Prostate Cancer NMCRPC Therapeutics Market All Set to Witness Massive Growth during Forecast to 2021-2031 | Fact.MR

Nonmetastatic Castrationresistant Prostate Cancer NMCRPC Therapeutics Market research Report is an inestimable supply of insightful data for business strategists. This Nonmetastatic Castrationresistant Prostate Cancer NMCRPC Therapeutics Market study provides extensive data which enlarge the understanding, scope, and application of this report.

A specified study of the competitive landscape of the global Nonmetastatic Castrationresistant Prostate Cancer NMCRPC Therapeutics Market has allow, providing insights into the corporate profiles, financial position, recent developments, mergers and acquisitions, and therefore the SWOT analysis. This analysis report will provide a patent subject to reader’s concern regarding the overall market situation to further choose on this market project.

Get Exclusive Free Sample Report: https://www.factmr.com/connectus/sample?flag=B&rep_id=5256

The report discusses in detail the various important aspects of the Nonmetastatic Castrationresistant Prostate Cancer NMCRPC Therapeutics market. The report has an intelligent insight on critical aspects that are essential to good growth in the Nonmetastatic Castrationresistant Prostate Cancer NMCRPC Therapeutics market. Some of these features include market size, growth, revenue, sales, demand, risks, threats, opportunities, economic forecast and history, and much more. The report is based on factual data assessed by our research analysts to give our clients a complete overview of the Nonmetastatic Castrationresistant Prostate Cancer NMCRPC Therapeutics market landscape and prepare a business canvas accordingly.

The Nonmetastatic Castrationresistant Prostate Cancer NMCRPC Therapeutics Market report profiles the successive companies, which includes: – Non-metastatic Castration-Resistant Prostate Cancer (nmCRPC) Therapeutics market are Astellas Inc., Johnson & Johnson, Sanofi S.A, Dendreon Corporation, and Bayer AG.

Fact.MR analysts are currently analyzing and coordinating their insights on the effect of COVID-19 across diverse industry verticals. These insights are quite promising for several businesses and ventures to cope up with this unprecedented downturn and take effective strategic decisions to expand and proliferate within a competitive business ecosystem.

Enquiry Before Buying: https://www.factmr.com/connectus/sample?flag=EB&rep_id=5256

Based on Therapy Type, Non-metastatic Castration-Resistant Prostate Cancer (nmCRPC) Therapeutics market is segmented into following;

  • Chemotherapy
  • Hormonal Therapy
  • Immunotherapy
  • Radiotherapy

Based on dose modality, global Non-metastatic Castration-Resistant Prostate Cancer (nmCRPC) Therapeutics market is segmented into following:

  • Oral tablets
  • Injections

Based on distribution channels, global Non-metastatic Castration-Resistant Prostate Cancer (nmCRPC) Therapeutics market is segmented into following

  • Hospital pharmacies
  • Pharmacies
  • Online pharmacies

Market Segment by Regions, regional analysis covers:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Middle East Africa

Pre Book This Report: https://www.factmr.com/checkout/5256

Reasons why you should buy this report:

Understand the Current and future of the Nonmetastatic Castrationresistant Prostate Cancer NMCRPC Therapeutics Market in both Established and emerging markets.
The report assists in relocating the business strategies by accentuate the Nonmetastatic Castrationresistant Prostate Cancer NMCRPC Therapeutics business priorities.
The report throws light on the segment anticipated to dominate the Nonmetastatic Castrationresistant Prostate Cancer NMCRPC Therapeutics industry and market.
Forecasts the regions expected to perceive ascension.
The newest developments within the Nonmetastatic Castrationresistant Prostate Cancer NMCRPC Therapeutics industry and details of the industry leaders alongside their market share and methods.
Saves time on the entry-level research as the report contains significant data concentrating growth, size, key players, and segments of the industry.
Save time carrying out entry-level research by characterizing the growth, size, major players and segments within the Global Market.

Explore Fact.MR’s Trending Report – https://www.globenewswire.com/en/news-release/2019/08/28/1907756/0/en/Absorbable-Surgical-Sutures-to-Witness-Rapid-Adoption-Key-Market-Players-Focus-on-Competitive-Pricing-Strategies-for-Extended-Outreach-Fact-MR.html

Why choose Fact.MR?

Reports published by Fact.MR are a result of the combination of our experts and digital technologies. We thrive to provide innovative business solutions to the clients as well as tailor the reports aligning with the clients’ requisites. Our analysts perform comprehensive research to offer ins and outs of the current market situation. Clients across various time zones tend to utilize our 24/7 service availability.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Pharmaceutical

Zellweger Spectrum Disorders Market: Production, Revenue, Price and Gross Margin Analysis with Forecasts to 2031!!

Zellweger Spectrum Disorders Market research Report is an inestimable supply of insightful data for business strategists. This Zellweger Spectrum Disorders Market study provides extensive data which enlarge the understanding, scope, and application of this report.

A specified study of the competitive landscape of the global Zellweger Spectrum Disorders Market has allow, providing insights into the corporate profiles, financial position, recent developments, mergers and acquisitions, and therefore the SWOT analysis. This analysis report will provide a patent subject to reader’s concern regarding the overall market situation to further choose on this market project.

Get Exclusive Free Sample Report: https://www.factmr.com/connectus/sample?flag=B&rep_id=5254

The report discusses in detail the various important aspects of the Zellweger Spectrum Disorders market. The report has an intelligent insight on critical aspects that are essential to good growth in the Zellweger Spectrum Disorders market. Some of these features include market size, growth, revenue, sales, demand, risks, threats, opportunities, economic forecast and history, and much more. The report is based on factual data assessed by our research analysts to give our clients a complete overview of the Zellweger Spectrum Disorders market landscape and prepare a business canvas accordingly.

The Zellweger Spectrum Disorders Market report profiles the successive companies, which includes: – PerkinElmers Inc., Trivitron Healthcare, Chromsystems Instruments & Chemicals GmbH., CENTOGENE N.V., LifeCell International Pvt. Ltd., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., F. Hoffmann-La Roche Ltd, Seimens.

Fact.MR analysts are currently analyzing and coordinating their insights on the effect of COVID-19 across diverse industry verticals. These insights are quite promising for several businesses and ventures to cope up with this unprecedented downturn and take effective strategic decisions to expand and proliferate within a competitive business ecosystem.

Enquiry Before Buying: https://www.factmr.com/connectus/sample?flag=EB&rep_id=5254

By therapy, the global Zellweger spectrum disorders market is further segmented into:

  • Pediatricians
  • Neurologists
  • Surgeons
  • Audiologists (treat hearing problems)
  • Ophthalmologists (treat vision problems)
  • Orthopedists (treat skeletal abnormalities)

By diagnosis, the global Zellweger spectrum disorders market is further segmented into:

  • Blood and Urine test
  • Ultrasound
  • Genetic tests

By end-user, the global Zellweger spectrum disorders market is further segmented into:

  • Hospitals
  • Clinics

Market Segment by Regions, regional analysis covers:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Middle East Africa

Pre Book This Report: https://www.factmr.com/checkout/5254

Reasons why you should buy this report:

Understand the Current and future of the Zellweger Spectrum Disorders Market in both Established and emerging markets.
The report assists in relocating the business strategies by accentuate the Zellweger Spectrum Disorders business priorities.
The report throws light on the segment anticipated to dominate the Zellweger Spectrum Disorders industry and market.
Forecasts the regions expected to perceive ascension.
The newest developments within the Zellweger Spectrum Disorders industry and details of the industry leaders alongside their market share and methods.
Saves time on the entry-level research as the report contains significant data concentrating growth, size, key players, and segments of the industry.
Save time carrying out entry-level research by characterizing the growth, size, major players and segments within the Global Market.

Explore Fact.MR’s Trending Report – https://www.globenewswire.com/en/news-release/2020/03/17/2001977/0/en/Demand-for-Hospital-Supplies-to-Heighten-with-Severing-Concerns-over-Hospital-Infections-Global-Market-Value-to-Surpass-US-21-Bn-by-2029-Fact-MR.html

Why choose Fact.MR?

Reports published by Fact.MR are a result of the combination of our experts and digital technologies. We thrive to provide innovative business solutions to the clients as well as tailor the reports aligning with the clients’ requisites. Our analysts perform comprehensive research to offer ins and outs of the current market situation. Clients across various time zones tend to utilize our 24/7 service availability.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Uveal Melanoma Treatment Market – Market Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031

Neonatal Dialysis Market – Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2021 to 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates